CCDR: Volume 49-10, October 2023: Influenza and Other Respiratory Infections

Table of contents

Advisory Committee Statement

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023–2024
A Sinilaite, W Siu, J Papenburg on behalf of the National Advisory Committee on Immunization (NACI)

Surveillance

National Influenza Annual Report, Canada, 2022–2023: Canada's first fall epidemic since the 2019–2020 season
K Schmidt, M Ben Moussa, S Buckrell, A Rahal, T Chestley, N Bastien, L Lee

Overview

Healthcare Costs and Effects of Post-COVID-19 Condition in Canada
E Rafferty, A Unsal, E Kirwin

Commentary

Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community
P De Wals, M Desjardins

Infographic

Infectious syphilis and congenital syphilis in Canada, 2022

Epidemiologic Study

Characteristics and clinical outcomes of nirmatrelvir/ritonavir (Paxlovid^TM) recipients in Canada, 2022: a descriptive cohort study
N Sicard, S Squires, M Mullah, P Daley

Current and future burden from Lyme disease in Québec as a result of climate change
M Ripoche, A Irace-Cima, A Adam-Poupart, G Baron, C Bouchard, A Carignan, F Milord, N Ouhoummane, PA Pilon, K Thivierge, K Zinszer, D Chaumont